Lv5
1340 积分 2022-10-25 加入
Donanemab in Early Symptomatic Alzheimer Disease
7天前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
9天前
已完结
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease
10天前
已完结
Donanemab in Early Symptomatic Alzheimer Disease
18天前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
18天前
已完结
The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial
18天前
已完结
Hereditary haemorrhagic telangiectasia
21天前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
2个月前
已完结
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease
3个月前
已完结
The role of Ligand-Binding Assay and LC–MS in the Bioanalysis of Complex Protein and Oligonucleotide Therapeutics
3个月前
已完结
皖公网安备34019202002308
